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Summary
Oncogene-induced cellular senescence (OIS) is well documented, but little is
known about how infinite cell proliferation induced by loss of tumor suppressor
genes is antagonized by cellular functions. Rb heterozygous mice generate Rb-
deificient C-cell adenomas that progress to adenocarcinomas following bialelic
loss of N-ras. Here, we demonstrate that pRb inactivation induces abberant
expression of farnesyl dipshosphate synthase, many of prenyltransferases and
their upstream regulators sterol regulatory element binding proteins (SREBPs) in
an E2F-dependent manner, leading to enhanced isoprenylation and activation of
N-Ras. Consequently, elevated N-Ras activity induces DNA damage response
(DDR) and p130-dependent cellular senescence in Rb-deficient cells.
Futhermore, Rb heterozygous mice additionally lacking any of Ink4a, Arf or
Suv39h1 generated C-cell adenocarcinomas, suggesting that cellular
senescence antagonizes Rb-deficient carcinogenesis.
SIGNIFICANCE
Aberration of the pRB pathway critically pertains to human carcinogenesis.
However, germ line RB mutations are detected in a limited variety of malignant
tumors, implicating the presence of defense mechanisms antagonizing RB-
deficient tumorigenesis. In this study, we attempted to clarify the mechanism by
which N-ras loci protect mouse C-cells and primary fibroblasts from Rb-loss-
induced carcinogenesis, and revealed a function of pRb in regulating post-
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translational modification of CAAX proteins. Our findings explain the tumor
suppressor function of N-Ras in certain types of cells lacking pRb. In addition,
since Ras proteins promote carcinogenesis in many cell types, our findings may
provide rational basis for the application of prenyltransferase inhibitors to human
cancers with aberrations in the pRB pathway.
 
Introduction
Carcinogenesis is induced by the breakdown of cellular functions that counteract
various oncogenic stimuli (Hanahan and Weinberg, 2000). OIS was first noted
as paradoxical growth arrest in human diploid fibroblasts induced by oncogenic
Ras (Collado et al., 2007). Currently, OIS is accepted as the cellular function that
antagonizes carcinogenesis, despite the presence of oncogenic mutation. The
study of melanocytic nevi carrying the BRAFV600E mutation provided the first
evidence of cellular senescence in human premalignant lesions (Mooi and
Peeper, 2006). Thereafter, the number of OIS inducers identified has been
rapidly increasing (Di Micco et al., 2007).
OIS is achieved by activating tumor suppressors including p16INK4a, ARF, pRB
and p53, or by inducing DDR activation engaged by H2AX, Chk2, p53 and ATM
before critical telomeric attrition occurs (Collado et al., 2007; Di Micco et al.,
2007). These cellular functions counteract infinite cell proliferation induced by
oncogenic signals. Accelerated cell proliferation induced by the loss of tumor
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suppressors can be counteracted by similar functions. For example, PTEN-loss-
induced prostate carcinogenesis is antagonized by p53-mediated senescence
(Chen et al., 2005), and VHL loss-induced cellular senescence is mediated by
pRB and p400 (Young et al., 2008). In human retinoblastoma, additional
aberration in p53 pathway is required for carcinogenesis (Laurie et al., 2006).
Nevertheless, we suspect that RB-deficiency in the human body can be
antagonized in many ways, because of the diversified functions of pRB and the
limited variety of mouse and human cell types that develop tumor with germ line
RB mutations (Wikenheiser-Brokamp, 2006).   
Rb+/- mice generate C-cell adenoma in the thyroid following somatic loss of the
normal Rb allele. Additional loss of N-ras alleles induces malignant conversion in
Rb-deficient C-cell adenoma. Moreover, somatic N-ras loss frequently occurs in
Rb+/-;N-ras+/- C-cells following Rb-loss, causing spontaneous malignant
conversion (Takahashi et al., 2006). The C-cell tumor phenotype observed in
Rb+/-;E2F3-/- mice (Ziebold et al., 2003) is similar to that in Rb+/-;N-ras-/- mice. It
was proposed that the Rb-E2F complex functions as a transcriptional repressor
to antagonize Ras signaling during vulval formation in Caenorhabditis.elegans
(Ceol and Horvitz, 2001). The Rb-ras genetic interaction during cell
differentiation, embryogenesis and tumorigenesis has been extensively
investigated in mice (Lee et al., 1999; Takahashi et al., 2003; Takahashi et al.,
2004; Takahashi et al., 2006), however, the core mechanism of this interaction
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has not yet been clarified. In this study, we seeked in vitro and in vivo evidence
that Rb-loss-induced cell proliferation in mouse C-cells and primary fibroblasts is
counteracted by an N-Ras-dependent senescence pathway, and attempted to
elucidate the mechanism by which pRb regulates N-Ras activation.   
Results
N-ras-dependent DDR and cellular senescence in Rb-deficient C-cell
adenoma
To investigate how N-Ras prevents Rb-deficient C-cell adenoma from
progressing to adenocarcinoma (Figure 1A), we analyzed primary C-cell tumors
developed in Rb+/-;N-ras+/+ (average age at examination (AE) ± standard error
(SE) = 11.0 ± 1.2 months) and Rb+/-;N-ras-/- (AE = 10.6 ± 0.9) mice. Proliferating
cell nuclear antigen (PCNA) and Ki-67 were frequently expressed in Rb-deficient
N-ras-/- adenocarcinomas, but their expression was invariably rare in Rb-
deficient N-ras+/+ adenomas (Figure 1B). On the other hand, Rb-deficient N-
ras+/+ adenomas frequently expressed DDR markers (Shiloh, 2003) including
H2AX phosphorylated at serine 139 (H2AX), ATM phosphorylated at serine
1981 (ATMpS1981) and p53 phosphorylated at serine 15 (p53pS15). These
markers were rarely detected in N-ras-/- adenocarcinomas (Figure 1B). In
addition, N-ras+/+ tumors frequently expressed senescence markers (Dimri,
2005) including histone H3 tri-methylated at serine 9 (H3K9me3),
heterochromatin protein 1 (HP1), p16Ink4a and senescence-associated--
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galactosidase (SA--gal) activity. These markers were rarely detected in N-ras-/-
adenocarcinomas (Figure 1B) or in adenocarcinomas spontaneously developed
in Rb+/-;N-ras+/- mice as a consequence of somatic loss of N-ras allele following
Rb-loss (Figure S1). These findings suggest that N-ras loci induce DDR and
cellular senescence during adenoma formation initiated by Rb-loss. We
therefore hypothesized that N-Ras prevents Rb-deficient C-cell adenomas from
progressing to adenocarcinomas by inducing DDR and cellular senescence.
To determine the sequence of events during development of an adenoma, we
compared Rb-deficient adenomas developed in younger Rb+/- mice (early
adenoma; AE = 6.2 ± 0.3) to those in older mice (late adenoma; AE = 11.0 ± 1.2).
DDR markers were expressed in early and late adenomas with similar
frequencies, however, senescence markers were less frequently expressed in
early adenomas (Figure S2). In contrast, PCNA and Ki-67 were more frequently
expressed in early adenomas than in late adenomas. These findings suggest
that DDR may precede cellular senescence during the development of C-cell
adenoma initiated by Rb-loss, and that early adenomas grow even in the
presence of DDR, but cease to grow when cellular senescence is induced.
Role of senescence-mediating genes in Rb-deficient C-cell adenoma
To examine whether cellular senescence protects Rb-deficient C-cell adenomas
from progressing to adenocarcinoma, we generated Rb+/- mice simultaneously
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lacking Ink4a, Ink4a and Arf-, Arf- or Suv39h1. All Rb+/-;Ink4a-/- mice survived
longer than 8 months (n = 12). The average age at the onset of sickness or
death (SD) was 9.3 ± 0.4 months in Rb+/-;Ink4a+/+ (n = 7), 9.5 ± 0.6 in
Rb+/-;Ink4a+/- (n = 3), and 9.7 ± 0.4 in Rb+/-;Ink4a-/- (n = 6) mice. No acceleration
of Rb-deficient pituitary tumorigenesis was observed in the Ink4a-/- background
(data not shown). All Rb+/-;Ink4a-/- mice exhibited large macroscopic tumors
stemming from the thyroid (Figure 2A and Table 1). Rb+/-;Ink4a+/- mice generated
macroscopic tumors, but these were smaller than those in Rb+/-;Ink4a-/- mice. No
macroscopic thyroid tumors were observed in Rb+/-;Ink4a+/+ mice. Histologically,
all thyroid tumors developed in Rb+/-;Ink4a-/- and Rb+/-;Ink4a+/- mice exhibited
features of C-cell adenocarcinoma (Figure 2B and Table 1) and were
histologically similar to tumors developed in Rb+/-;N-ras-/- mice. Rb+/+;Ink4a-/-
mice showed no evidence of microscopic thyroid tumor. Rb-deficient Ink4a-/-
cells separated from primary tumors grew in tissue culture and expressed
calcitonin (5 successful cultures from 6 attempts with independent tumors)
(Figure 2C), as did Rb-deficient N-ras-/- C-cell adenocarcinoma cells. However,
no clonally expanding calcitonin-positive cells were derived from thyroids
harboring Rb-deficient Ink4a+/+ tumors (0/6), suggesting that, as did Rb-deficient
N-ras-/- C-cells, Rb-deficient Ink4a-/- C-cell tumor cells had acquired the ability to
infinitely proliferate. Therefore, we diagnosed tumors developed in Rb+/-;Ink4a-/-
mice as C-cell adenocarcinomas. These findings suggest that C-cell
carcinogenesis initiated by Rb-loss is blocked by Ink4a.
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Rb+/-;Ink4a-/-;Arf-/- (SD = 5.3 ± 0.1; n = 9) and Rb+/-;Arf-/- (SD = 4.7 ± 0.2; n = 3)
mice died of lymphoma, sarcoma or, more often, of accelerated pituitary tumor
growth as described previously (Tsai et al., 2002), before they developed
macroscopic thyroid tumors. However, at 4.8 months, Rb+/-;Ink4a-/-;Arf-/- mice
developed large microscopic adenocarcinomas with a morphology different from
that of Rb-deficient N-ras-/- or Rb-deficient Ink4a-/- tumors (Figure 2B).
Rb+/+;Ink4a-/-;Arf-/- mice of the same age or older showed no evidence of
microscopic thyroid tumor (Table 1). In Rb+/-;Arf-/- mice (AE = 5.2 ± 0.3) but not in
Rb+/+;Arf-/- mice, we often observed large microscopic adenocarcinomas with
morphologies different from those in Rb-deficient N-ras-/-, Rb-deficient Ink4a-/- or
Rb-deficient Ink4a-/-;Arf-/- tumors. Tumor cells separated from Rb+/-;Ink4a-/-;Arf-/-
(3/3) and Rb+/-;Arf-/- (2/2) mice grew in tissue culture and expressed calcitonin.
However, in an Arf-/- background, regardless of the Ink4a genotype, and despite
the frequent PCNA and Ki-67 expression and infinite growth in culture, the
frequency of carcinoembryonic antigen (CEA)-positive C-cell tumor cells was low
(Figure 2B and Table 1). This suggests a specific genetic interaction between Arf
and CEA. Rb+/-;Suv39h1-/- mice (AE = 4.6 ± 0.2) exhibited macroscopic tumors
(Figure 2A and Table 1) that grew in tissue culture (2/2) (Figure 2C), and
frequently expressed CEA, PCNA and Ki-67 (Figure 2B and Table 1). These
findings suggest that p16Ink4a, Arf and Suv39h1 antagonize Rb-deficient C-cell
carcinogenesis.
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Role of N-Ras in Rb-deficient C-cell carcinogenesis
We generated 11 cell lines from independent primary Rb-deficient N-ras-/- thyroid
tumors, all of them were calcitonin positive (data not shown). Six cell lines were
less adhesive. Five adhesive cell lines were competent for transfection and
infection. After transduction of N-Ras or N-RasV12, all of the adhesive cell lines
grew without immediate growth arrest or cell death for a minimum of 5 days.
Moreover, upon subcutaneous inoculation into nude mice, one of the adhesive
cell lines, AC61, produced tumors histologically similar to primary Rb-deficient
N-ras-/- tumors. Importantly, this cell line generated smaller subcutaneous tumors
with features of Rb-deficient adenomas when reconstituted with N-Ras at a level
comparable to that of endogenous N-Ras expressed in an Rb-positive and ret
mutation-positive human C-cell adenocarcinoma cell line TT (Tomoda et al.,
2008) (Figure 3A).
Nine days after N-ras transduction, we observed a marked induction of DDR
(Figure 3B). Comet assay detected a high frequency DNA double strand breaks
in N-Ras-transduced cells within 10 days (Figure 3C). At day 14, senescence
markers including Suv39h1, H3K9me3 and HP1 recruited to the chromatin,
p16Ink4a, p19Arf and nuclear p130 were readily detectable (Figure 3D and E). We
also detected senescence-associated heterochromatin foci (SAHF) (Narita et al.,
2003) (Figure 3D) and high SA--gal activity (Figure 3F). The other 4 cell lines
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(AC55, 62, 65 and 69) responded to N-Ras in a manner similar to AC61 (Figure
S3). We did not detect telomerase (mTERT) expression in AC61 cells. The AC55
cell line was telomerase-positive. However, N-Ras transduction did not
significantly change mTERT expression nor telomerase activity in AC55 cells,
excluding the possibility of replicative senescence (Figure S4A-C). These
findings indicate that in the absence of pRb, N-Ras induces DNA damage and
cellular senescence that functions as a barrier against C-cell carcinogenesis.
p130-dependent differential functions of wild-type and oncogenic N-Ras in
the absence of pRb
When introduced into AC61 cells, N-RasV12 was far less efficient at inducing
DDR and senescence markers (Figure 3B-E), growth arrest and SA--gal
activity (Figure 3F), compared to N-Ras. Further, we observed only a slight
decrease in the proliferation of pRb-reconstituted AC61 cells suggesting that
AC61 cells were reprogrammed to be no more addicted to Rb-loss (Figure 3F).
The effects of N-Ras and N-RasV12 in inducing cellular senescence were
reversed after pRb reconstitution (Figure 3F). These findings suggest that pRb
attenuates N-Ras function to induce cellular senescence in AC61 cells and that
N-RasV12 fails to activate alternative cellular senescence programs when pRb is
unavailable.
We observed that p130 was markedly induced and accumulated in the nuclei of
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AC61 cells transduced with N-Ras, but not in AC61 cells transduced with N-
RasV12 (Figure 3E and G). Nuclear p130 was complexed with Suv39h1,
H3K9me3 and HP1 in the presence of N-Ras, but not N-RasV12 (Figure 3G). In
consistent, we detected the colocalization of p130 and HP1 signals in the nuclei
of N-Ras-reconstituted cells (Figure 3G). N-Ras failed to induce cellular
senescence in AC61 cells when p130 was depleted beforehand by specific
shRNAs (Figure 3H and S5A). Moreover, p130 depletion at day 14 after N-Ras
transduction, significantly reversed cellular senescence (Figure 3I and S5B).
These findings suggest that p130 is required for induction and maintenance of
N-Ras-induced cellular senescence in Rb-deficient cells. We also observed
significant p130 induction in primary C-cell adenomas developed in Rb+/-;N-ras+/+
mice, but not in adenocarcinomas developed in Rb+/-;N-ras-/- mice (Figure 3J).
Taken together, these findings suggest that induction of p130 is critical for
cellular senescence induced by N-Ras in Rb-deficient C-cell adenocarcinoma
cells, and that N-RasV12 fails to induce cellular senescence in these cells due to
inability to induce p130.
Rb
-/-;N-ras-/- MEFs escape cellular senescence
To generalize our observation on C-cells, we characterized mouse embryo
fibroblasts (MEFs) prepared from Rb-/- embryos with various N-ras genotypes.
During the serial passages according to the 3T3 protocol (Todaro and Green,
1963), Rb-/-;N-ras-/- MEFs achieved infinite proliferation significantly earlier than
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Rb-/- MEFs (Figure 4A). Rb-/-;Ink4a-/- MEFs exhibited proliferative characteristics
similar to those of Rb-/-;N-ras-/- MEFs.
Rb-/-;N-ras-/- MEFs but not Rb+/+;N-ras+/+, Rb-/-;N-ras+/+ or Rb+/+;N-ras-/- MEFs,
could form colonies when plated at low cell density (Figure 4B). Moreover,
shRNA-directed N-Ras depletion in Rb-/- MEFs allowed them to form colonies
under the same conditions (Figure 4C). Further, Rb-/-;Ink4a-/- MEFs formed
colonies when plated at low cell density, which was suppressed by p16INK4a.
Colony formation by Rb-/-;N-ras-/- MEFs was suppressed by N-Ras, pRb or
p16INK4a, but not by N-RasV12 (Figure 4D). N-RasN17 did not reduce colony
numbers, albeit at smaller colony size, suggesting that the function of N-Ras in
colony suppression depends on GTP. The colony suppression in Rb-/-;N-ras-/-
MEFs induced by N-Ras was due to cellular senescence (Figure 4E and S6). N-
RasV12 and other activated Ras isoforms did not induce cellular senescence but
induced transformation in Rb-/-;N-ras-/- MEFs (Figure 4E and F). However, Rb+/+;
N-ras-/- MEFs (Figure 4E) and wild-type MEFs (data not shown) were senesced
by N-RasV12. A previous study demonstrated that Rb-/-;p107-/-;p130-/- MEFs
escaped cellular senescence and were efficiently transformed by H-RasV12
(Sage et al., 2000). Similarly, Rb-/-;N-ras-/- MEFs were transformed by all
isoforms of RasV12 (Figure 4F). These findings suggest that MEFs can be
transformed by RasV12 once exempted from senescence program, and thereby
support the hypothesis that Rb-/-;N-ras-/- MEFs escaped cellular senescence.
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Finally, to further elucidate the differential functions of N-Ras and N-RasV12 in the
absence of pRb, both proteins were simultaneously expressed in Rb-/-;N-ras-/-
MEFs. N-Ras was dominant over N-RasV12 in inducing DDR and most of the
senescence markers, but N-RasV12 antagonized N-Ras activity to induce p16Ink4a
in the absence of Rb (Figure S6). These findings suggest that N-Ras and N-
RasV12 exert many different biological functions in the absence of Rb. To explain
this difference, we analyzed the activation mechanisms of them in the studies
discussed below.
pRb attenuates N-Ras activity in C-cell adenocarcinoma
To address why N-Ras and N-RasV12 exert different functions in the absence of
pRb, we again analyzed AC61 cells. N-Ras expressed in AC61 cells was
significantly activated, however, the activity was decreased to 10.4% (9.6 to 1.0)
when pRb was simultaneously expressed under the influence of a strong
promoter (Figure 5A). The relative activation level of N-RasV12 (65.1) was 6.8
times higher than that of N-Ras (9.6) in the absence of pRb. The activity of N-
RasV12 was also attenuated by pRb, but this attenuation was less efficient (65.1
to 37.5) than that of N-Ras (9.6 to 1.0). Freshly introduced exogenous pRb was
hyperphosphorylated when coexpressed with N-RasV12 compared to N-Ras
(Figure 5A) as previously shown (Peeper et al., 1997). We therefore considered
that hypophosphorylated pRb is more potent than hyperphosphorylated pRb in
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suppressing N-Ras activity. These findings suggest that in the absence of pRb,
the activation level of N-Ras is moderate yet significantly lower than that of N-
RasV12. This may at least partially explain the differential functions of N-Ras and
N-RasV12 in the absence of pRb.
pRb delays N-Ras isoprenylation
To explore the mechanism of N-Ras activation control by pRb, we transduced
AC61 cells with moderately expressed pRb using titer-known retrovirus
(multiplicity of infection at 1.0). We then transiently transduced these cells with
the monomeric-VenusA207R-tagged N-Ras (Venus-N-Ras). The higher molecular
weight endowed by tagging provided us with a better separation of proteins
during SDS-PAGE. In addition, rapid analysis immediately after completing
transfection and under optimal conditions enabled us to detect cytosolic
(unprenylated) Venus-N-Ras proteins on IB and image analyses before the
majority of them become isoprenylated. In cells growing in 10% FBS, the
moderate expression of pRb attenuated Venus-N-Ras activity to almost half
(Figure 5B). However, under this condition, the difference in the migration
degree of Venus-N-Ras was barely noticeable. When we decreased FBS to
0.5% in an attempt to enhance pRb activity, we observed an increased
proportion of the unprenylated form only in the presence of pRb. Under this
condition, the majority of pRb was hypophosphorylated. This effect of pRb was
comparable to that of prenyltransferase inhibitors (PTIs), and was reversed by 1
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hr serum restimulation. However, Venus-N-Ras activation upon serum
restimulation was significantly delayed in the presence of pRb or PTIs (Figure
5B). We observed the same effect of pRb on N-Ras isoprenylation in another
Rb-deficient N-ras-/- cell line (AC62) (Figure 5C). These findings suggest that
pRb delays N-Ras isoprenylation and activation.  
pRb downregulates membrane trafficking of N-Ras
We observed an increased proportion of unprenylated N-Ras on IB in pRb-
positive cells only when cultured under low serum conditions. N-Ras in the
isoprenylated fractions include not only those anchored to the plasma
membrane, but also those anchored to endomembranes such as Golgi, ER and
other vesicles. Thus, a considerable proportion of N-Ras are membrane-
anchored but not always activated. Therefore, we next investigated the effects of
pRb on subcellular localization of N-Ras. We cotransfected Venus-N-Ras and
red fluorescent protein (RFP)-tagged Rab6A (RFP-Rab6A) as a Golgi marker
without the CAAX motif (Goud et al., 1990). Twelve hours after transfection in
10% FBS, Venus-N-Ras overlapping with RFP-Rab6A became detectable in
both pRb-negaive and positive cells (Figure 5D). From then, we decreased FBS
concentration to 0.1% for 12 hr and observed that the signal overlap was barely
detectable in pRb-positive cells, whereas it was readily detectable in pRb-
negative cells. The abundance and subcellular localization of RFP-Rab6A were
not affected by pRb status nor by serum depletion. PTIs exhibited the same
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effect as pRb during serum depletion.  Under these conditions (0.1% FBS for
12 hr), we observed that in the absence of pRb, about half of the Venus-N-Ras
was isoprenylated and enriched in the membrane fraction, whereas in the
presence of pRb, most of the Venus-N-Ras was still unprenylated and remained
in the cytosolic fraction (Figure 5D).  After 18 hr serum depletion, we observed
a slight recovery in the signal overlap in pRb-positive cells. Serum restimulation
enabled the recovery of signal overlap to the initial level after 2 hr (Figure 5D).
These findings suggest that the serum concentration influences the pRb function
in reducing N-Ras in Golgi at a particular time point. Disappearance of Venus-
N-Ras from Golgi can be explained by downregulated transport to Golgi due to
the decreased isoprenylation.
Next, to examine whether delayed membrane trafficking attenuates N-Ras
activation, we observed AC61 cells cotransfected with Venus-N-Ras and RFP-
Rab6A using a confocal laser microscope. After 24 hr culture in 10% FBS and
subsequent 48 hr culture in 0.1% FBS, the overlap of Venus-N-Ras and RFP-
Rab6A signals was significantly higher in pRb-negative than pRb-positive cells,
however, the Venus-N-Ras signal was not detectable at the plasma membrane
in both cells (Figure 5E and S7). Notably, 10 min after serum restimulation, a
strong Venus-N-Ras signal was detected in the periphery of pRb-negative, but
not pRb-positive cells (Figure 5E and S7). These observations suggest that pRb
delays Venus-N-Ras transport to Golgi by attenuating endomembrane anchoring
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and thereby delays further trafficking to the plasma membrane. We further
speculated that N-Ras-induced cellular senescence in Rb-deficient C-cells
depends on isoprenylation, as the N-RasSAAX (N-RasS186) mutant that cannot be
isoprenylated completely failed to induce DDR and cellular senescence in AC61
cells (Figure 5F) or to suppress colony formation by Rb-/-;N-ras-/- MEFs (data not
shown). Similarly, treatment with PTIs significantly suppressed N-Ras-induced
DDR and cellular senescence in AC61 cells (Figure 5G). We finally examined
whether Rb-loss increases N-Ras isoprenylation. Venus-N-Ras was introduced
into Rb+/+ and Rb-/- MEFs. Upon serum starvation, started 8 hr after transfection,
Rb-/- MEFs exhibited faster isoprenylation of Venus-N-Ras protein compared to
littermate Rb+/+ MEFs (Figure 5H and S8), suggesting that Rb-loss in MEFs
accelerates N-Ras isoprenylation.  
pRb downregulates genes involved in isoprenylation
A previous study demonstrated that the influence of pRb on Ras activity
depended on de novo protein synthesis (Lee et al, 1999). We therefore
performed microarray analysis on AC61 cells freshly transduced with moderately
expressed pRb. These cells were maintained unsynchronized in 10% FBS,
which allowed the cells to attenuate N-Ras activity to half (Figure 5B). Genes
significantly upregulated by pRb included many cell surface antigens,
lymphokines, interferons and inflammation-related genes (Figure S9), similar to
previous results obtained by analyzing MEFs conditionally lacked pRb (Markey
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et al., 2007). Moreover, in genes significantly downregulated by pRb, we
detected known E2F-target genes such as Cdc6, N-myc and Mmp-3 with the
highest statistical significance (change p-value >0.99998 determined by
Wilcoxon’s signed rank test), suggesting that pRb reconstitution was successful
(Table S1).
In 396 significantly upregulated genes (change p-value <0.001), we did not
detect genes that could be directly involved in suppressing Ras activity such as
GTPase activating protein. In 270 significantly downregulated genes (change p-
value >0.9998), we found that farnesyl diphosphate farnesyl transferase 1
(Fdft1) had the highest rank (Table S1). In addition, we detected number of
genes (Table S2) predicted to be transactivated by SREBPs via sterol regulatory
element (SRE) (Sakakura et al., 2001). Other genes that could be directly
involved in stimulating Ras activation, such as GTP-exchange factor or receptor
tyrosine kinase were not detected. We then analyzed pRb-reconstituted AC61
cells by RT-PCR. Surprisingly, in addition to Fdft1, farnesyl diphosphate
synthase (Fdps) (Szkopinska and Plochocka, 2005), most of the
prenyltransferases (Fnta: farnesyltransferase , Fntb: farnesyltransferase ,
Pggt1b: protein geranylgeranyltransferase 1 and Rabggtb: Rab
geranylgeranyltrasferase ) (Maurer-Stroh et al., 2003) and SREBP-1, SREBP-
2 were significantly downregulated by pRb. All these genes were induced in
MEFs following Rb-loss or pRb inactivation using SV40 large T antigen or
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adenovirus E1A (Figure 6A). A farnesyltransferase  immunoblot validated the
results of the RT-PCR (Figure 6B). We did not detect a significant change in NF1
(Courtois-Cox et al., 2006) expression (data not shown).
To investigate the in vivo relevance of the increased expression of genes
involved in protein isoprenylation in Rb-deficient cells, primary Rb-deficient C-
cell adenomas were immunohistochemically analyzed. These tumors expressed
significantly higher levels of Fntb, SREBP-1 and SREBP-2 compared to normal
thyroid tissue (Figure 6C). We then compared expression level of these proteins
between pRb-positive ret mutation-positive human medullary thyroid carcinoma
(C-cell) cell line TT (Tomoda et al., 2008) and AC61. AC61 cells expressed
significantly higher levels of Fnta, Fntb and SREBP-1, SREBP-2 compared to TT
cells (Figure S10).
E2F-dependent transcription control of genes involved in isoprenylation
To further investigate the mechanism by which pRb controls genes involved in
protein isoprenylation, we analyzed the promoter regions of these genes. We
detected several E2F-binding consensus sequences in the promoter regions of
SREBPs (Figure S11). Moreover, we detected several E2F-binding consensus
sequences in each of the promoters of Fdps and prenyltransferases. These
findings suggest that E2Fs control Fdps and prenyltransferases via a dual
mechanism involving SREBPs and direct binding. ChIP assay detected the
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direct binding of E2F-1 and E2F-3 to the promoters of these genes specifically in
the absence of pRb (Figure 6D). E2F-3 exhibited stronger DNA binding activity
to the Fntb promoter than E2F-1. We also detected direct binding of pRb to the
Fdps promoter. pRb prevented SREBPs binding to the Fdps promoter, probably
via downregulation of SREBPs. Further, a pRb mutant derived from a
retinoblastoma and lacking the ability to attenuate Ras activation (Lee et al.,
1999) could not bind to the Fdps promoter and did not suppress SREBPs
binding. However, a partially penetrant mutant pRb (Sellers et al., 1998) with the
ability to attenuate Ras activation (Lee et al., 1999) bound to the Fdps promoter
and suppressed SREBPs binding (Figure S12), suggesting that the function of
pRb to attenuate Ras activation is not separable from its ability to regulate the
Fdps promoter and SREBPs.  
Fdps, Fntb and SREBP-1 promoters were downregulated by pRb. This effect
was augmented by serum depletion. These promoters were upregulated by
either E2F-1 or E2F-3 (Figure 6E). In particular, E2F-3 was more potent than
E2F-1 in transactivating the Fntb promoter, in agreement with the ChIP results
(Figure 6D). The truncated mutant E2F containing the DNA-binding domain but
lacking the transactivation domain (E2F-DB) slightly, but significantly,
downregulated these promoters, suggesting the involvement of liberated E2Fs in
the basal transactivation. Except for the Fntb promoter, which lacks SRE, Fdps
and SREBP-1 promoters were upregulated by SREBP-1c. The dominant
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negative SREBP-1c downregulated the basal transactivation of these two
promoters, indicating increased endogenous SREBP activity in AC61 cells.
Further, these three promoters were downregulated by pRb in two other pRb-
negative cells (Rb-/-;N-ras-/- MEFs and Saos2). Transduction of E2F-DB, SV40
large T antigen or adenovirus E1A in MEFs induced Fdps promoter
transactivation (Figure 6E). E2F-DB is known to affect the functions of E2Fs in
multiple ways: one is to derepress active transcriptional silencing by the pRb-
E2F complex (Rowland et al., 2002). Thus, we considered that the pRb-E2F
complex directly participates in the transcriptional repression of Fdps.  
pRb-dependent protein farnesylation  
The CAAX motif constitutes a C-terminal tetrapeptide common to all Ras,
directing multi-step post-translational modifications initiated by farnesyl
transferases (Hancock, 2003). There are approximately 300 proteins with the
CAAX motif that are potentially farnesylated. To investigate pRb’s effects on
these proteins, we analyzed AC61 cells or MEFs that were metabolically labeled
with [3H]farnesol. In 10% FBS, pRb-negative cells showed an increased density
of farnesylated protein bands. When serum was depleted, this difference
became higher (Figure 6F and S13). These findings suggest that Rb-loss
induces enhanced global protein farnesylation.
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Clinical relevance of pRb-N-Ras pathway in MTCs
Human medullary thyroid carcinomas (MTCs) are pathologically similar to C-cell
adenocarcinomas in the mice analyzed in this study. Human C-cell adenoma is
extremely rare. Familial MTCs are frequently associated with mutation in the ret
oncogene, however, almost half of sporadic MTCs are free of the ret mutation
(Marsh et al., 2003) indicating the ret-independent mechanism involved in
human C-cell carcinogenesis. To address the relevance of the pRb-N-Ras
pathway in human tumors, we analyzed 13 sporadic MTCs, of which, 6 cases
(46%) were immunohistochemically negative for pRb and 7 cases (54%) were
negative for N-Ras (Figure 7A). Notably, 6 of 7 N-Ras-negative tumors were
negative for pRb (Figure 7B). This finding in human is consistent with the
requirement of N-Ras suppression in Rb-deficient C-cell carcinogenesis in mice.
Discussion
The current work has provided evidence that in the absence of pRb, E2F-1 and
E2F-3 participate in the transactivation of most of the genes involved in protein
isoprenylation either directly or via SREBPs. This at least partially explains Ras
activity elevation induced by pRb inactivation (Figure S14A). It would be of
interest to ascertain whether under physiological conditions, Ras and pRb
activities oscillate due to the mutual suppression via cyclinD/Cdk4/6 and
E2F/isoprenylation (Figure S14B). Further, this study partially clarified the
mechanism of the tumor suppressor function of wild-type Ras. It has previously
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been shown that loss of the normal ras allele, in addition to activating mutation,
was required for tumorigenesis (refs in Zhang et al., 2001). This study indicated
that N-Ras and N-RasV12 exert different functions in Rb-deficient cells where only
N-Ras can induce p130-dependent cellular senescence, which explains why N-
Ras V12 requires pRb to induce cellular senescence.
Cell cycle-dependent Ras activation was noted by Taylor and Shalloway (1997).
Later, it was discovered that pRb inactivation (Raptis et al., 1997) or genetic loss
(Lee et al., 1999) elevates Ras activity. The latter study observed that high N-
Ras activation was sharply induced in serum starved Rb-/- MEFs only 10 min
after serum restimulation. We suspect that during serum starvation, pRb-
negative cells pool greater numbers of N-Ras-GDP molecules in space where
GDP to GTP exchange readily occurs upon serum restimulation. Indeed, our
results suggest that isoprenylated Ras-GDP proteins are aberrantly enriched in
the Golgi complex in pRb-negative cells during serum starvation. At Golgi, Ras is
activated through src-mediated activation of phospholipase C. The nature of
Ras signaling generated from Golgi is supposed to be distinct from that
generated from plasma membrane in terms of activation of JNK, ERK, AKT and
Ral pathways (Hancock, 2003; Quatela and Philips, 2006). Therefore, in addition
to moderate level activation, enrichment of N-Ras in Golgi in Rb-deficient cells
may assign a specific role to itself.
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Simultaneous N-ras or K-ras deletion rescues differentiation defects in Rb-null
embryos and prolongs life span with no detectable impact on E2F-dependent
ectopic proliferation and apoptosis (Takahashi et al., 2003; Takahashi et al.,
2004). This is in line with our observation that the isoprenylation-dependent
regulation of Ras activation is genetically downstream of E2Fs in the absence of
pRb (Figure S14A). The limited effect of E2Fs deletion on differentiation defects
in Rb-/- embryos can be explained by the redundant functions shared by E2F
family members. Indeed, deletion of individual E2F in Rb-/- embryos resulted in
varying degrees of rescue of erythropoiesis (Wikenheiser-Brokamp, 2006;
Dirlam et al., 2007). The extended life span in Rb-deficient embryos achieved by
additionally deleting N-ras was obviously due to the rescue of hepatic anemia
(Takahashi et al., 2003). Although the etiology of Rb-deficient anemia is still
controversial, a significant genetic interaction seems to exist between E2Fs and
N-ras in Rb-mediated erythropoiesis. Furthermore, common C-cell tumor
phenotypes in Rb+/-;E2F-3-/- and Rb+/-;N-ras-/- mice, the senescence-inducing
activity of E2F-3 in vivo (Lazzerini Denchi et al., 2005) and the role of E2F-3 in
regulating the transcription of genes involved in Ras isoprenylation (this study)
suggest that E2F-3 and N-ras are genetically linked in Rb-deficient C-cell
carcinogenesis.
Our observation of less frequent senescence markers, compared to DDR, in
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early Rb-deficient adenomas indicates that chronologically DDR precedes the
appearance of senescence markers during adenoma formation. However, this
does not necessarily mean that Rb-loss-induced DNA damage is a prerequisite
for inducing cellular senescence. To further address this issue, we are analyzing
Rb+/-;ATM-/- mice (AS and CT unpublihsed). The RB pathway has been linked to
DDR through E2F-dependent pathways (Pickering and Kowalik, 2006) involving
cyclin E (Tort et al., 2006) or Mad2 (Hernando et al., 2004). Our study proposes
that N-Ras or other isoprenylated proteins may participate in accumulating DNA
double strand breaks in Rb-deficient cells.
This study also elucidates the tumor suppressor roles of p130, p16INK4a, ARF
and Suv39H1 in the absence of pRb. Despite the role of p53 in human
retinoblastoma, Rb+/-;p53+/- mice produce C-cell adenocarcinoma at a lower
frequency (8%) following spontaneous mutation in the ret oncogene (Coxon et
al., 1998) compared to Rb+/-;N-ras-/- mice (91.6 %). This suggests that
particularly in C-cells, the lower p53 activity acts independently to increase
genomic instability rather than intimately cooperating with the pRb pathway.
This study also explains the tumor-promoting function of wild-type Ras observed
in Rb-deficient pituitary glands (Takahashi et al., 2004; Takahashi et al., 2006)
and immortalized fibroblasts (Raptis et al., 1997; Fotiadou et al., 2007). OIS is
known to occur in limited cell types, but activated Ras promotes carcinogenesis
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in many cell types. Further, not only Ras but also other isoprenylated proteins
such as Ras2, RhoA, RhoB, RhoC, RhoE, Rac1, Rac2, Cdc42, Rheb, TC10,
TC21, RalA, Rap1A, Rap1B, Rap2, Rab8, Rab11, Rab13, CENP-E, CENP-F
(Maurer-Stroh et al., 2003) may be orchestrated by pRB via E2Fs. We have
previously detected upregulated RhoA, Rac and Cdc42 activities in Rb-deficient
cells (Takahashi et al., 2006). Finally, we emphasize that our study provides
rational basis for applying PTIs to pRB-inactivated tumors without somatic ras
mutations such as retinoblastoma, osteosarcoma and small cell lung carcinoma.
Experimental procedures
Animals
Rb+/- mice with various N-ras genotypes were described (Takahashi et al., 2006).
Rb+/- mice were crossed with Ink4a-/-, ARF-/-, Ink4a-/-;ARF-/- or Suv39H1-/- mice,
and the resultant progeny was intercrossed to generate mice used in this study.
Average age at examination (AE) was determined irrespective of the mouse
status. Mouse genotyping is described in Supplemental Experimental
Procedures. The protocol of this study was approved by the ethical committee of
Kyoto University Graduate School of Medicine, and animals were handled in
accordance with the guidelines of Kyoto University.
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Cell Culture
Primary C-cell adenocarcinoma cell lines were established as described
(Takahashi et al., 2006) with minor modifications. MEFs were prepared from
E12.5 embryos derived by intercrossing Rb+/-;N-ras+/- or Rb+/-;Ink4a+/- mice.
Comet Assay
CometAssay Reagent Kit was purchased from Trevigen (4250-050K).
RNA Interference   
MISSION TRC shRNA target sets (TRCN0000071271, 71274 for p130 and
34391, 34392, 34393 for N-Ras) and TurboGFP shRNA control vector (SHC004)
were purchased from Sigma-Aldrich.
BrdU incorporation
BrdU incorporation was measured as described previously (Takahashi et al.,
2004).
Colony Formation Assays
Colony formation was assessed by plating 1.0 x 103 cells per 60 mm dish. After
14 days cultivation, giemsa staining was used to visualize colonies. Suppression
of colony formation was observed by transfecting 1.0 x 105 MEFs with 0.5 μg
pLXSB and 5 μg pBabe-puro expressing the indicated proteins, followed by 14
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days cultivation with 8 μg/ml blasticidin S.
Ras Activation Assay
Pull-down assay to measure N-Ras activity was performed as described
previously (Lee et al., 1999).
Prenylation Assay
Cells transiently transfected with pCAGGS-VenusA207R-N-Ras were lysed as
described (Miki et al., 2007), sonicated for 3 cycles of 15 s each, and separated
on 8~10 % acrylamide SDS-PAGE gel at a low constant voltage (less than 40 V
for longer than 36 h). FTI-I (#344150), FTI-277 (#344555) and GGTI-298
(#345883) were purchased from Calbiochem.  
RT-PCR
Total RNA was extracted using RNeasy Mini Kit from Qiagen (74104) and RT-
PCR was performed using TaKaRa RNA PCR Kit (RR019A) and the sequence
specific primers indicated in Table S3.
Chromatin Immunoprecipitation
ChIP reagents (SC-45000, 45001, 45002 and 45003) were purchased from
Santa Cruz Biotechnology. Lysates were immunoreacted with specific antibodies.
Released DNA was amplified by PCR using the primers indicated in Table S4.




5 x 106 cells were cultured in 10% FBS with 10 mM Lovastatin for 4 hr. After
removing Lovastatin, the cells were incubated with 1.54 MBeq [3H]farnesol in the
presence of 10% FBS for 4 hr and then in the presence of 10% or 0.5% FBS for
additional 20 hr. Labeled proteins were analyzed as described previously
(Andreas et al., 1999).  
Human Tumor
Tumors from patients with MTC were surgically removed at the Department of
Endocrine Surgery and diagnosed at the Department of Pathology, Tokyo
Women’s Medical University. The protocol of this study was approved by the
ethical committee of Tokyo Women’s Medical University and informed consent
was obtained from all patients.
SUPPLEMENTAL DATA
Supplemental Data include Experimental Procedures, references, 14 figures and
4 tables.
Microarray data
Microarray data are deposited at:
http://www.ncbi.nlm.nih.gov/projects/geo/query/acc.cgi?acc=GSE12637.
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Figure legends
Figure 1. Analysis of C-cell tumors in Rb+/-;N-ras+/+ and Rb+/-;N-ras-/- mice.
(A) Scheme of C-cell carcinogenesis in Rb+/- mice drawn based on previous
findings.
(B) Immunohistochemical (IHC) analysis and SA--gal assay of thyroid and C-
cell tumors in mice with the indicated genotypes. 22 Rb+/-;N-ras+/+ (AE = 11.0 ±
1.2) and 28 Rb+/-;N-ras-/- (AE = 10.6 ± 0.9)mice were analyzed. Scale bars: 100
μm. The frequency of immuno-stain positive cells per 200 normal thyroid or
tumor cells is quantified. Columns are mean + SE.
Figure 2. C-cell tumor phenotypes in Rb+/- mice additionally lacking
senescence-mediating genes.
(A) C-cell tumors (indicated by arrows) developed in mice with the indicated
genotype and age (months). Scale bars: 3 mm.
(B) Histological and IHC analysis of C-cell tumors developed in mice with the
indicated genotype and age. Scale bars: 100 μm.
(C) Calcitonin staining of cultured tumor cells prepared from thyroids of mice with
the indicated genotype. Scale bars: 100 μm.
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Figure 3. Effects of N-Ras reconstitution in Rb-deficient N-ras-/- C-cell
adenocarcinoma.
(A) Immunoblot (IB) analysis of TT and AC61 cells infected with pBabe-puro
(vector) or pBabe-puro-N-ras for the indicated proteins (top). Histological and
IHC analysis of AC61 cells infected with pBabe-puro or pBabe-puro-N-ras,
selected, and cultured subcutaneously in BALB/c-nu/nu mice for 14 days
(middle). Primary C-cell tumors from mice of the indicated genotype are
illustrated (bottom). Scale bars: 100 μm. Tumor weights and frequency of
immuno-stain positive cells per 200 tumor cells are quantified (right). Columns
are mean + SE from 4 tumors each.
(B) Immunofluorescence (IF) analysis of AC61 cells infected with pBabe-puro
vectors expressing the indicated proteins, selected, and cultured for additional 8
days. Blue signals: DAPI. Scale bars: 10 μm.
(C) Comet assay of cells from (B). Scale bars: 30 μm. Cells with DNA double
strand breaks per 200 cells are quantified. Numbers are mean ± SE from 3
experiments.
(D) IF analysis of cells prepared as in (B) and cultured for additional 12 days.
Scale bars: 10 μm.
(E) IB of acid-extracted (H2AX, Suv39h1, H3K9me3, HP1) or whole cell
lysates (others) from cells prepared as in (B) and cultured for additional 9 days.
NT: non-treated, H2O2: treated with 200 μM H2O2 for 30 min at 4 oC, SS: serum
starved in 0.1% FBS for 24 hr.
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(F) AC61 cells were infected with pBabe-puro vectors expressing the indicated
proteins, and selected (upper). AC61 cells infected with pLXSB or pLXSB-Rb,
and selected were re-infected with pBabe-puro vectors expressing the indicated
proteins, and selected (lower). Cell proliferation was monitored from day 6
onwards and SA--gal activity was detected at day 11 after the last infection.
Scale bars: 30 μm.
(G) Immunoprecipitation (IP) from whole cell lysates (WCL) or chromatin fraction
(CH) of cells prepared as in (B) and cultured for additional 9 days (left). HP1
bound to p130 or Suv39h1 in the chromatin fraction are the upper bands.
Colocalization of p130 and HP1 in these cells is demonstrated (right). Scale
bars: 5 μm.
(H) AC61 cells were infected with lentivirus expressing the indicated shRNAs,
and selected with puromycin. Five days after the initial infection, cells were re-
infected with pLXSB or pLXSB-N-ras, selected, and analyzed. BrdU
incorporation determined by FACS and IB at day 6 after the last infection are
shown. Bars are mean + SE from dupilcate experiments.
(I) AC61 cells were transduced with the indicated shRNAs 14 days after N-Ras
transduction and analyzed as in (H). Bars are mean + SE from dupilcate
experiments.
(J) IHC analysis of thyroids or primary C-cell tumors developed in mice of the
indicated genotypes. Scale bars: 100 μm. Quantification was performed as in (A).
Columns are mean + SE (n 20 each).
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Figure 4. Rb-N-ras genetic interaction in MEFs.
(A) 3T3 protocol assay of MEFs with the indicated genotypes. Cumulative
multiplicity in the representative cultures at the indicated passage number is
shown.
(B) Representative results of colony formation assays of MEFs with the indicated
genotypes plated at low density. Results are quantified. Bars are mean + SE (n =
6).
(C) Rb-/- MEFs infected with lentivirus expressing the indicated shRNAs,
selected, plated at low density, re-infected every 5 days for 3 times, and cultured
for 21 days from the initial infection (top). IB analysis of cells infected one time
with the indicated lentiviruses is shown (bottom).
(D) Colony suppression assay of MEFs with the indicated genotypes
cotransfected with pLXSB and pBabe-puro vectors expressing the indicated
proteins, and selected. Bars are mean + SE (n = 4).
(E) SA--gal assay of MEFs with the indicated genotypes infected with pBabe-
puro vectors expressing the indicated proteins, selected, and cultured for 9 days.
Scale bars: 100 μm.
(F) Proliferation of MEFs with the indicated genotypes infected with pBabe-puro
vectors expressing the indicated proteins, or pMIKcys (K-RasV12). After selection,
1.0 x 105 viable cells were plated on 100 mm dish (day 6) and cell number was
counted at the indicated time points.
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Figure 5. Effects of pRb on N-Ras isoprenylation and membrane trafficking.
(A) AC61 cells transfected with 0.25 μg pBabe-puro-N-ras or pBabe-puro-N-
rasV12 together with 2.5 μg pSG5 or pSG5L-HA-Rb were selected, and analyzed
for GTP-bound N-Ras or status of the indicated proteins in the presence of 10%
FBS. Pull down of GTP-loaded N-Ras was done using Glutathione S-transferase
(GST)-fused Ras-binding domain (RBD) of Raf. N-Ras-GTP/Total ratio in the
presence of N-Ras and pRb (lane2) was set to 1.0 (underlined), and relative N-
Ras activity in other lanes was estimated.
(B) AC61 cells infected with pLXSB or pLXSB-Rb and selected were transiently
transfected with pCAGGS-VenusA207R-N-Ras, treated under the indicated
conditions, and analyzed for N-Ras prenylation status (upper 3 cases) and
activity (lower 3 cases). PTIs represent the mixture of prenyltranfrase inhibitors
(FTI-II, FTI-277 at 10 μM and GGTI-298 at 2 μM). Unprenylated (UP) and
prenylated (P) Venus-N-Ras proteins are indicated by arrows. The status of
transduced pRb in each condition is indicated (right).
(C) Another Rb-deficient N-ras-/- C-cell tumor line AC62 was analyzed in 0.5%
FBS as in (B).
(D) AC61 cells prepared as in (B) and cotransfected with pCAGGS-VenusA207R-
N-Ras (green) and pCXN2-RFP-Rab6A (red) were monitored using fluorescent
microscope under the indicated conditions. Scale bars: 40 μm. Merged signals
(arrows) are shown (top). Relative intensity of signals in Golgi (RFP-Rab6A-
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positive area) was measured using NIH image J 1.4 program and quantified at
the indicated time points (lower left). Results are mean ± SE from 90 cells
observed in 3 experiments. Cells cultured in 0.1% FBS for 12 hr were lysed and
fractionated. C: cytosolic, M: membranous, W: whole cell lysates (lower right).  
(E) AC61 cells were cotransfected with 0.25 μg pCAGGS-VenusA207R-N-Ras
(green) and 0.25 μg pCXN2-RFP-Rab6A (red) together with 2.5 μg pCMV or
pCMV-Rb. Cells were grown in 10% FBS for 24 hr, serum starved in 0.1 % FBS
for additional 48 hr, then restimulated with 10% FBS, and analyzed at the
indicated time points using a laser confocal fluorescence microscope. Scale
bars: 10 μm. Signal intensity of Venus-N-Ras in the cell periphery was measured
using NIH image J 1.4 program and quantified from observation of 50 cells each.
Bars are mean + SE from 3 experiments.
(F) AC61 cells were transfected with pBabe-puro, pBabe-puro-N-ras or pBabe-
puro-N-rasS186, selected and analyzed after 12 days.
(G) AC61 cells were transfected with pBabe-puro or pBabe-puro-N-ras, selected,
treated with 2.5 μM FTI-II, 2.5 μM FTI-277 and 0.5 μM GGTI-298 or with vehicle
(DMSO), and analyzed as in (F). Amido black stain is shown as a loading
control.
(H) Paired MEFs with the indicated genotypes were transfected with Venus-N-
Ras for 8 hr, grown under 0.5% FBS for 24 hr or treated with PTIs as in (G), and
analyzed. Prenylated and unprenylated fractions of total Venus-N-Ras are
quantified. Another pair of MEFs is shown in Figure S8.
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Figure 6. E2F-dependent transcriptional control of enzymes involved in protein
isoprenylation.
(A) RT-PCR of the indicated genes in AC61 cells infected with pLXSB or
pLXSB-Rb, and pBabe-puro or pBabe-puro-N-ras in the indicated combinations
and selected, MEFs infected with pBabe-neo-TAg or control vector, Rb+/+ and
Rb-/- MEFs cultured in 0.1% FBS for 24 hr, or MEFs infected with pBabe-hygro-
E1A or vector control and selected. SV40LT: Simian virus 40 large T antigen,
E1A: adenovirus E1A.
(B) IB of fanesyltransferase  in AC61 cells expressing the indicated protein and
in Rb-/- and Rb+/+ MEFs.
(C) IHC analysis of wild-type thyroids and Rb-deficient C-cell adenomas. Scale
bars: 100 μm. Quantification was done as in Figure 1B.
(D) ChIP assay of the indicated gene promoters in AC61 cells infected with
pLXSB or pLXSB-Rb. Positions and sequences of the primers in mouse genome
are shown in Figure S11 and Table S4.
(E) Luciferase activity in the indicated cells transfected with pGL3 containing the
indicated luciferase reporters together with pCMV--gal and following expression
vectors: pSG5L-HA-Rb, pcDNA3-HA-E2F-1, pcDNA3-HA-E2F-3, pBabe-puro-
E2F-DB, pSV-Sport-SREBP-1c, pSV-Sport-dominant negative (DN)-SREBP-1c,
pBabe-neo-TAg or pBabe-hygro-E1A. Empty vectors were used as control under
the same conditions, and results are normalized by -gal activity. Relative
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luciferase activities are shown as the controls set to 1.0. Bars are mean + SE
(n3).
(F) Visualization of 3H-farnesylated proteins in AC61 cells prepared as in (D) and
treated under the indicated conditions. Coomassie stain is shown as a loading
control.
Figure 7. Analysis of human sporadic MTCs.
(A) IHC analysis of sporadic human MTCs. Of 13 cases analyzed, representative
cases are shown. Scale bars: 100 μm.        
(B) Chi-square analysis (Fisher’s exact test) showing the correlation between
pRb and N-Ras expression in 13 sporadic human MTCs. P value is indicated
(Chi2 = 9.55).
Table 1. Pathological diagnosis of thyroids derived from mice with the indicated
genotypes. Average age at examination (AE), number of analyzed thyroids (N),
histological diagnosis (adenoma: AD or carcinoma: CA), mean diameter of
tumors (MD), percentage of CEA, PCNA or Ki-67 positive cells in tumors are
indicated ± SE. (--): No data, NA: not analyzed.
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Supplemental Experimental Procedures 
 
Mouse Genotyping  
Mouse genotyping was performed as described previsouly (Jacks et al., 1992; Sharpless et al., 
2001; Kamijo et al., 1999; Serrano et al., 1996; Peters et al., 2001). 
 
Antibodies 
For immunohistochemistry, immunofluorescence or immunoblotting, mouse or rabbit antibodies 
specific to the following proteins were used: PCNA (SC-7907, Santa-Cruz Biotechnology (SC)), 
Ki-67 (AB15580, Abcam), γH2AX (05-636, Upstate), ATMpS1981 (200-301-500, Rockland) (for 
immunohistochemistry only), p53pS15 (PC386, Calbiochem), Trimethyl histone H3 (Lys9) 
(H3K9me3) (07-442, Upstate), HP1γ (MAB3450, Chemicon), p16INK4a (SC-1661, SC), Calcitonin 
(SC-20725, SC), CEA (AB33562, Abcam), ATMpS1981 (200-301-400, Rockland), Suv39H1 
(AB12405), ARF (AB80, Abcam), p107 (SC-318, SC), p130 (SC-56178, SC), Chk2pT68 (AB38461, 
Abcam), p21 (556430, BD), N-Ras (OP25, Calbiochem), α-Tubulin (CP06, Calbiochem), pRb 
(554136, BD), Farnesyltransferase β (SC-4664, SC), Farnesyltransferase α (SC-13964, SC), 
SREBP-1 (SC-13551, SC) and SREBP-2 (SC-13552, SC). For immunoprecipitation, rabbit 
antibodies specific to Suv39H1 (SC-25366, SC), p130 (07-282, Upstate) and mouse antibody to 
pRb (MK-15-3, MBL) were used. For Ras activity and prenylation assay, mouse antibody specific to 
 N-Ras (OP25, Calbiochem) was used. For ChIP assay, mouse antibodies specific to E2F-1 
(SC-193, SC), E2F-3 (SC-878, SC), pRb (MK-15-3, MBL), SREBP-1 (SC-13551, SC) and 
SREBP-2 (SC-13552, SC) were used. 
 
Immunohistochemistry  
Paraffin embedded mouse C cell tumors or human MTCs were deparaffinized, rehydrated and 
unmasked in 0.25 mM EDTA at 95oC for 50 min. Tissue sections were immunostained using Dako 
Envision kit (K1390) and counterstained with hematoxylin. 
 
Retroviruses and Plasmids 
pBabe-puro-N-ras, N-rasV12, N-rasN17, H-rasV12 were made by subcloning cDNAs from pLenti6/V5 
vectors previously described (Takahashi et al., 2006). pBabe-puro-N-rasSAAX (N-rasS186) was 
generated by introducing a Cysteine to Serine mutation into N-Ras by using PCR with mutated 
oligoncletide. pBabe-puro-p16INK4a (Alevizopoulos et al., 1997), pBabe-puro-E2F-DB (Rowland et 
al., 2002), pBabe-neo-TAg (Hahn et al., 2002), pCMV-pRb (Qin et al., 1992) and pCMV-β-gal 
(Takahashi et al., 2003) were described previously. pLXSB-Rb was made by subcloning the cDNA 
from pSG5-Rb (Shirodkar et al., 1992). pGL3-Fdps-luc (position, –1601~-1 from the predicted 
transcription initiation site), pGL3-Fntβ-luc (position, -2141~+267) and pGL3–SREBP-1-luc 
(position, -2161~+872) were made by subcloning C57BL/6 mouse genomic DNAs amplified by 
PCR. pSV-Sport-SREBP-1c, its dominat negative mutant (Tontonoz et al., 1993) and pGL3-FAS-luc 
(Kim et al., 1998) were purchased from Addgene (Boston, MA) with the permission from B. 
Spiegelman. pCXN2-RFP-Rab6A was a gift from T. Taguchi, pCAGGS-VenusA207R-N-Ras (A207R 
stands for an Alanine to Arginine mutation intruoduced into Venus protein in an aim to make it 
monomeric) from M. Matsuda, and pcDNA3-HA-E2F-1 and pcDNA3-HA-E2F-3 from S. Gaubatz. 
For retrovirus production, EcoPak2 (Clontech) cells were used. Retrovirus expressing K-RasV12 
(pMIKcys) was a gift from M. Noda. Transfection of C cell tumor cell lines and MEFs was done 
using FuGene6 (Roche). AC61 cells or MEFs transduced with pBabe-puro or pLXSB vectors were 
slected with 4 μg/ml puromycin or 8 μg/ml blasticidin S respectively for 36~48 hr.  
 
Immunofluorescence  
Texas red-conjugated goat anti-mouse or Alexa Fluor-conjugated 488 goat anti-rabbit antibody 
(T862 and A11034 respectively, Molecular Probes) was used as the secondary antibody. DNA was 
 visualized by 4’, 6-diamino-2-phenylindole (DAPI). 
 
Senescence-Associated β-Galactosidase Assays 
SA-β-gal assay was performed in vitro as described previously (Dimri et al., 1995). For in situ assay, 
tissues were fixed in 4% paraformaldehyde (PFA) in phosphate buffered saline (PBS) for 12 hr at 
4Co, incubated in 70% ethanol for 24 hr at 4oC, and embedded in paraffin. Four µm sections were 
prepared on lysine-coated glass slides, deparaffinized, rehydrated, and unmasked with 0.25 mM 
EDTA for 50 minutes at 95 oC. Tissue sections were stained in 40 mM Citric acid, 40 mM NaPO4, 5 
mM K4[Fe(CN)6], 5 mM K3[Fe(CN)6], 150 mM NaCl, 2 mM MgCl2, 0.02% NP-40 (pH 6.0) with 1 
mg/ml 5-bromo-4-chloro-3-indolyl-β-D-galactoside (X-gal) for 16 hr at 37 oC. 
 
Immunoblotting 
Whole cell lysates were prepared in buffer (Miki et al., 2007) or in acid-extraction buffer (Fischle et 
al. 2005) as described previously. 
 
Cell Fractionation  
Cell fractionation was performed as described previously (Amin et al. 2003). 
 
Immunoprecipitation 
Whole cell lysates or chomatin fraction was extracted as described previously (Miki et al., 2007; 
Fischle et al., 2005) and immunoreacted with specific antibodies.  
 
Telomerase Detection 
Cells were infected with pBabe-puro or pBabe-puro-N-ras, selected with 4 µg/ml puromycin for 2 
days, and analyzed either by TRAP assay or immunoblotting 11 days after the initial infection. 
TRAP assay was performed using TRAPEZE telomerase detection kit from Chemicon (S7700) 
according to the manufacturer’s protocol. The mTERT immunoblotting was performed using 
anti-telomerase specific antibody from Calbiochem (582000) as described previously (Kharbanda 
et al., 2000). 
 
FLAG-Tagged N-Ras 
pBabe-puro-N-ras was used as a template for PCR using sense 
 5’-GAGGAATTCATGGATTACAAAGATGACGATGACAAAACTGAGTACAAACTGGTGGTGGTT-
3’ and antisense 5’-GACGGGATCCTTACATCACCACACATGGCA-3’ primers to generate a 




Ten two-dimensional (2D) slices at 1 μm thickness each taken by confocal laser fluorescence 
microscope (Fluoroview; Olympus) were assembled to generate thee-dimensional (3D) images 
using FV300 image analysis program (Olympus).  
 
Microarray 
1.0 x106 AC61 cells were infected with titer known retrovirus derived from pLXSB or pLXSB-Rb, 
and selected with 8 μg/ml blasticidin S for 36 hr. Resultant cells were grown for 48 hr without 
blasticidin S in 10% FBS, harvested on ice, and quickly frozen. RNA was extracted and analyzed by 
using Genechip mouse 430.2 (Affymetrix) and DNA MicroArray viewer (KURABO, Japan) at the 
microarray core facility of KURABO Co. (Neyagawa, Osaka, Japan).  
 
Promoter Analysis  
2 kb upstream and 1 kb downstream of the predicted transcription initiation site of genes in genomic 
DNA sequences were retrieved from the mouse genome informatics (MGI) data base or from 
human genome database provided by GenBank. The sequences were searched for the sterol 
responsive element (SRE) at http://motif.genome.jp/ and E2F binding consensus sequences at 
http://compel.bionet.nsc.ru/FunSite/SiteScan.html as previously reported (Nahle et al. 2003). 
Accession numbers of genome sequences containing each gene are as following: Fdft1, 102706 
for mouse and NC_000008 for human; Fdps, 104888 and NC_000001; Fnta, 104683 and 
NC_000008; Fntb, 1861305 and NC_000014; Pggt1b, 1917514 and NC_000005; Rabggtb, 99537 
and NC_000001; SREBP-1, 107606 and NC_000017, and SREBP-2, 107585 and NC_000022.  
 
ChIP Assay of Fdps Promoter in AC61 Cells Transfected with pRb Mutants 
2.5 μg of pSG5L-HA-pRb∆ex22 or pSG5L-HA-pRb∆ex4 (Sellers et al., 1998) were introduced into 
AC61 cells together with 0.25 μg pLSXB, and selected with 8 μg/ml blatsticidin S. Resultant cells 
were analyzed by ChIP assay using the same antibodies and primers as used in Figure 6D (lower 
 panel). Position and sequence of these primers in Fdps gene promoters are indicated in Figure S11 
and Table S4 (Fdps*).  
 
Luciferase Assay 
5.0 x 103 AC61 or 1.0 x 104 Rb-/-;N-ras-/- MEFs, Saos2 cells or wild-type MEFs were transfected with 
0.125 μg of luciferase reporter constructs and 0.125 μg pCMV-β-gal together with 0.25 ~1.25 μg 
expression vectors. Luciferase activity and β-gal activity in cells was measured 48~72 hr after 
transfection as described previously (Takahashi et al., 2003). β-gal activity was used to normalize 
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Figure S1. Analysis of Rb-Deficient C Cell Tumors that Acquired Somatic Loss of 
N-ras 
Immunohistochemical analysis of the serial sections of C cell tumors developed in 
Rb+/-;N-ras+/- mice that have not (-) or have acquired (+) somatic loss of wild-type N-ras 
allele following Rb-loss. Antibodies specific to the indicated proteins were used. Scale 




Figure S2. Frequency of DDR and Cellular Senescence Markers in Rb-Deficient C 
Cell Early Adenomas and Late Adenomas 
Thyroid glands of the indicated age of Rb+/- mice were analyzed. Tumors were stained 
with antibodies specific to the indicated proteins. Frequency of positive cells in 





Figure S3. N-Ras Induced DDR and Cellular Senescence in Other Rb-Deficient 
N-ras-/- C Cell Adenocarcinoma Cell Lines Similar to AC61 
AC62, one of other cell lines independently prepared from C cell tumor developed in an 




Figure S4. Effect of N-Ras on Telomerase Activity in Rb-Deficient Cells 
(A) MCF-7 cells, Rb-/-;N-ras-/- MEFs and AC61 cells (parental and those infected with 
pBabe-puro or pBabe-puro-N-ras) were analyzed for TERT expression by 
immunoblotting.  
(B) Immunoblot analysis of mTERT expression levels in another C cell adenocarcinoma 
cell line (AC55) infected with pBabe-puro or pBabe-puro-N-ras, selected and cultured  
for 7 days. #1 and #2 were independently established.  
(C) The telomeric repeat amplification protocol (TRAP) assay of cells analyzed in panel 
(B). Heat inactivation was performed to suppress telomerase activity. 36 base pair bands 
are internal control.  




Figure S5. Proliferation of AC61 Cells Transduced with N-Ras and shRNA Targeting 
p130 
(A) AC61 cells were infected with lentivirus expressing the indicated shRNAs, and 
selected with puromycin. After 5 days from the initial infection, resultant cells were 
infected with pLXSB or pLXSB-N-ras, selected with blasticidin S, and analyzed. Growth 
curve from day 5 onwards after the last infection is shown. 
(B) AC61 cells were infected with pLXSB or pLXSB-N-ras, and selected with blasticidin 
S. After 14 days from the initial infection, resutant cells were infected with lentivirus 
expressing the indicated shRNAs, selected with puromycin, and analyzed. Growth curve 




Figure S6. Differential Functions of N-Ras and N-RasV12 in Inducing DDR and 
Cellular Senescence in Rb-/-;N-ras-/- MEFs 
Rb-/-;N-ras-/- MEFs were simultaneously infected with retroviruses derived from the 
indicated plasmids, and selected with blasticidin S and puromycin. Resultant cells were 
cultured for 12 days, and analyzed by immunoblotting. Antibodies specific to the 
indicated proteins were used.  
 
  
Figure S7. 3D Imaging of Venus-N-Ras and RFP-Rab6A in AC61 Cells in the 
Absence or Presence of pRb 
Cells analyzed in Figure 5D were further analyzed at the indicated levels by the 3D 
method. Scale bars = 10 μm. Intensity of green signals in the 3D image at the level 
indicated by yellow line is measured using NIH ImageJ 1.4 program.  
 
  
Figure S8. Accelerated N-Ras Isoprenylation in Rb-Deficient MEFs 
Another pair of MEFs was examined as in Figure 5H. 
 
  
Figure S9. Microarray Analysis of AC61 Cells Reconstituted with pRb 
(A) Dot blot presentation of the microarray analysis comparing gene expression profiles in 
pLSXB and pLXSB-Rb-infected AC61 cells. RNA was extracted at 72 hr after  
viral infection. X-axis represents expression level in pLSXB, and Y-axis in pLXSB-Rb  
infected cells.  
(B) Simplified ontology of 396 significantly upregulated genes with p value < 0.001  
determined by Wilcoxon’s Signed Rank test.  
  
Figure S10. Correlation of the pRb Status and the Expression of Proteins Involved in 
Protein Isoprenylation 
TT cells (pRb-positive human C cell cancer line) and AC61 cells infected with 






 Figure S11. E2F- and SREBP-Binding Consensus Sequences on the Promoter of 
Genes Downregulated by pRb 
Schematic presentation of promoter structure of the indicated genes on human and mouse 
genome. Positions of the DNA binding consensus sequence for E2Fs and SREBPs are 
indicated. Probability of each E2F binding consensus sequence in mouse genome is 
provided as score number in the parenthesis. The positions of ChIP primers used in Figure 
6D and Figure S12 are indicated by arrows. The primers for Fdps promoter used in the 
lower panel of Figure 6D are indicated with asterisks (*). The sequence of these primers is 













Figure S12. ChIP Assay of SREBPs and pRb Binding to the Fdps Promoter in AC61 
Cells Infected with pRb Mutants 
Binding of the indicated proteins to Fdps promoter in AC61 cells expressing the indicated 
pRb mutant was analyzed by ChIP assay. The positions of primers are shown in Figure 
S11 (*) and their sequence in Table S4 (Fdps*).  
  
 
Figure S13. Global Visualization of Farnesylated Proteins in MEFs 
MEFs with the indicated genotypes were treated under the indicated conditions and 
analyzed as in Figure 6F.  
 
  
Figure S14. Current Model of the Rb-N-ras Genetic Interaction in Mouse C Cells 
and MEFs 
(A) The signaling pathway which is generated by pRb and flows into Ras.  
(B) Circuitry functional relationship between pRb and Ras. 
 
 Table S1. Twenty-Six Genes Downregulated by pRb with the Highest Confidence (Change p 
Value > 0.99998 Determined by Wilcoxon’s Signed Rank Test) in Microarray Analysis Using 
Genechip Mouse 430.2 (Affymetrix) 
Gene Description                             Accesion Number       Functional Category 
α4-tubulin 
Matrix metalloproteinase-3      




Squalene epoxidase       
Grb14     
Cdc6       
EST 
Glycine C-acetyltransferase     





Cytochrome p450      
Atp6v0b        
N-myc          
Timm9                                   
Transferrin receptor 
EST 
Chondroitin sulfate proteoglycan 2          
EST 
EST 






















































 Table S2. Possible SREBP-Targeted Genes Found in 270 Genes Downregulated by pRb with 
Significantly High Confidence (Change p Value > 0.9998 Determined by Wilcoxon’s Signed 
Rank Test) in Microarray Analysis Using Genechip Mouse 430.2 (Affymetrix) 
Gene Description           Change p Value 
Farnesyl diphosphate farnesyl transferase 1                    
Squalene epoxidase            
Stearoyl-Coenzyme A desaturase 2   
Sterol-C5-desaturase     
Acetyl CoA transferase-like protein   
NAD(P)-dependent steroid dehydrogenase-like protein  
Mevalonate diphospho decarboxylase          
Caveolin 2       
Biotin acetyl-CoA-carboxylase          
Hydroxysteroid (17-β) dehydrogenase 7         
Isopentenyl-diphosphate delta isomerase   













 Table S3. RT-PCR Primer Sequences  
Gene                Sense (5’→3’)                      Antisense (5’→3’) 


























TCCACCACCCTGTTGCTGT     
Orientation and sequence of DNA primers used in RT-PCR of the indicated genes. Sequences 
were retrieved from GenBank (Fdft1, NM_010191; Fdps, NM_134469, Fnta, NM_008033; Fntb, 
NM_145927; Pggt1b, NM_172627; Rabggt, NM_011231; SREBP-1, NM_011480; SREBP-2, 








Table S4. ChIP Primer Sequences 
















Orientation and sequence of DNA primers used in ChIP assays of the indicated genes in the upper 
panel of Figure 6D. Fdps* represents the primer set used in the lower panel of Figure 6D and Figure 
S12. Their positions in mouse genome are indicated in Figure S11. 
